BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20562467)

  • 1. Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.
    Dickerson BC; Wolk DA;
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):45-51. PubMed ID: 20562467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
    Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
    Wolk DA; Dickerson BC;
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.
    Mez J; Cosentino S; Brickman AM; Huey ED; Manly JJ; Mayeux R
    PLoS One; 2013; 8(6):e65246. PubMed ID: 23755200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia.
    Stopford CL; Thompson JC; Neary D; Richardson AM; Snowden JS
    Cortex; 2012 Apr; 48(4):429-46. PubMed ID: 21237452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysexecutive syndrome in amnesic mild cognitive impairment: a multicenter study.
    Blanco Martín E; Ugarriza Serrano I; Elcoroaristizabal Martín X; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Uterga Valiente JM; Indakoetxea Juanbeltz MB; Moraza Lopez J; Barandiarán Amillano M; Fernández-Martínez M
    BMC Neurol; 2016 Jun; 16():88. PubMed ID: 27260328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis.
    Scheltens NM; Galindo-Garre F; Pijnenburg YA; van der Vlies AE; Smits LL; Koene T; Teunissen CE; Barkhof F; Wattjes MP; Scheltens P; van der Flier WM
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):235-43. PubMed ID: 25783437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisaccade task reflects cortical involvement in mild cognitive impairment.
    Heuer HW; Mirsky JB; Kong EL; Dickerson BC; Miller BL; Kramer JH; Boxer AL
    Neurology; 2013 Oct; 81(14):1235-43. PubMed ID: 23986300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
    Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI.
    Mukherjee S; Trittschuh E; Gibbons LE; Mackin RS; Saykin A; Crane PK;
    Brain Imaging Behav; 2012 Dec; 6(4):649-60. PubMed ID: 23161456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
    Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT
    Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly.
    Luck T; Then FS; Luppa M; Schroeter ML; Arélin K; Burkhardt R; Thiery J; Löffler M; Villringer A; Riedel-Heller SG
    Neuropsychology; 2015 May; 29(3):382-387. PubMed ID: 25365563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.
    d'Oleire Uquillas F; Jacobs HIL; Hanseeuw B; Marshall GA; Properzi M; Schultz AP; LaPoint MR; Johnson KA; Sperling RA; Vannini P
    Neuroimage Clin; 2018; 17():388-396. PubMed ID: 29159051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.